Snyder Capital Management L P Has $30.50 Million Stock Position in STERIS plc (NYSE:STE)

Snyder Capital Management L P raised its stake in shares of STERIS plc (NYSE:STE - Free Report) by 15.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 148,384 shares of the medical equipment provider's stock after purchasing an additional 20,087 shares during the period. Snyder Capital Management L P owned 0.15% of STERIS worth $30,502,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Avalon Trust Co bought a new stake in shares of STERIS in the fourth quarter valued at approximately $30,000. Human Investing LLC bought a new stake in shares of STERIS in the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC boosted its position in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division boosted its position in shares of STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after acquiring an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its position in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after acquiring an additional 137 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analysts Forecast Growth

STE has been the subject of several research reports. JMP Securities reissued a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. Stephens reissued an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research report on Monday, April 7th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Price Performance

STERIS stock traded down $1.19 during trading hours on Wednesday, hitting $222.85. 319,362 shares of the stock were exchanged, compared to its average volume of 529,074. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The stock has a market capitalization of $21.90 billion, a P/E ratio of 47.31 and a beta of 0.87. STERIS plc has a 12 month low of $200.98 and a 12 month high of $248.24. The business's 50-day moving average is $223.03 and its two-hundred day moving average is $218.87.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.